Bryce V Johnson, Mark Sonderman, Matthew J Magoon, Andrew Pistner, Bishoy Hanna, Graham H Bevan, Rosemary McDonagh, Patrick M Boyle, Melissa Robinson, Nazem Akoum, Neal A Chatterjee, Eric V Krieger, Babak Nazer
{"title":"法洛氏四联症的慢传导解剖峡部:预防性 \"VT消融的机会。","authors":"Bryce V Johnson, Mark Sonderman, Matthew J Magoon, Andrew Pistner, Bishoy Hanna, Graham H Bevan, Rosemary McDonagh, Patrick M Boyle, Melissa Robinson, Nazem Akoum, Neal A Chatterjee, Eric V Krieger, Babak Nazer","doi":"10.1016/j.hrthm.2024.10.073","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with repaired Tetralogy of Fallot (rTOF) are at risk of ventricular tachycardia (VT) and sudden cardiac death (SCD). Most VTs arise from 5 slowly conducting isthmuses (SCAI; conduction velocity ≤ 0.5 m/s) bound by the right ventriculotomy, ventricular septal defect patch, tricuspid and pulmonic valves. Historically, risk stratification electrophysiology studies (EPS) involved programmed ventricular stimulation (PVS) with VT induction guiding ICD implantation and/or VT ablation.</p><p><strong>Objective: </strong>To evaluate a \"prophylactic\" strategy of ablating SCAI even in the absence of inducible VT to reduce ICD implantation and arrhythmic events, and to compare this to the \"historical\" strategy.</p><p><strong>Methods: </strong>This was a single-center, retrospective cohort study. The \"historical cohort\" underwent PVS to guide ICD implantation and/or VT ablation. The \"prophylactic cohort\" underwent right ventricular electroanatomic mapping and ablation of SCAI. A composite endpoint of arrhythmic death, cardiac arrest, sustained VT, and ICD complication was compared between the cohorts.</p><p><strong>Results: </strong>Ninety-three patients with rTOF had risk stratification EPS. Of 57 prophylactic patients, SCAI were identified/ablated in 33 (58%), 16 (28%) had inducible VT before ablation, and 1 received ICD. Of 35 historical patients, 15 (43%) had inducible VT: 3 had cryoablation during PVR and 11 received ICD. No prophylactic patients met the composite endpoint over median 21 months (IQR 8,35) versus 10 (29%) historical patients over median 125 months (IQR 90,142; p= 0.017). There were no ablation-related complications.</p><p><strong>Conclusion: </strong>Prophylactic SCAI ablation is associated with fewer ICD implants and a reduction in incident arrhythmic events without ablation-related complications.</p>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":" ","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Slowly Conducting Anatomic Isthmuses of Tetralogy of Fallot: An Opportunity for \\\"Prophylactic\\\" VT Ablation.\",\"authors\":\"Bryce V Johnson, Mark Sonderman, Matthew J Magoon, Andrew Pistner, Bishoy Hanna, Graham H Bevan, Rosemary McDonagh, Patrick M Boyle, Melissa Robinson, Nazem Akoum, Neal A Chatterjee, Eric V Krieger, Babak Nazer\",\"doi\":\"10.1016/j.hrthm.2024.10.073\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Patients with repaired Tetralogy of Fallot (rTOF) are at risk of ventricular tachycardia (VT) and sudden cardiac death (SCD). Most VTs arise from 5 slowly conducting isthmuses (SCAI; conduction velocity ≤ 0.5 m/s) bound by the right ventriculotomy, ventricular septal defect patch, tricuspid and pulmonic valves. Historically, risk stratification electrophysiology studies (EPS) involved programmed ventricular stimulation (PVS) with VT induction guiding ICD implantation and/or VT ablation.</p><p><strong>Objective: </strong>To evaluate a \\\"prophylactic\\\" strategy of ablating SCAI even in the absence of inducible VT to reduce ICD implantation and arrhythmic events, and to compare this to the \\\"historical\\\" strategy.</p><p><strong>Methods: </strong>This was a single-center, retrospective cohort study. The \\\"historical cohort\\\" underwent PVS to guide ICD implantation and/or VT ablation. The \\\"prophylactic cohort\\\" underwent right ventricular electroanatomic mapping and ablation of SCAI. A composite endpoint of arrhythmic death, cardiac arrest, sustained VT, and ICD complication was compared between the cohorts.</p><p><strong>Results: </strong>Ninety-three patients with rTOF had risk stratification EPS. Of 57 prophylactic patients, SCAI were identified/ablated in 33 (58%), 16 (28%) had inducible VT before ablation, and 1 received ICD. Of 35 historical patients, 15 (43%) had inducible VT: 3 had cryoablation during PVR and 11 received ICD. No prophylactic patients met the composite endpoint over median 21 months (IQR 8,35) versus 10 (29%) historical patients over median 125 months (IQR 90,142; p= 0.017). There were no ablation-related complications.</p><p><strong>Conclusion: </strong>Prophylactic SCAI ablation is associated with fewer ICD implants and a reduction in incident arrhythmic events without ablation-related complications.</p>\",\"PeriodicalId\":12886,\"journal\":{\"name\":\"Heart rhythm\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2024-11-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heart rhythm\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.hrthm.2024.10.073\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart rhythm","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.hrthm.2024.10.073","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Slowly Conducting Anatomic Isthmuses of Tetralogy of Fallot: An Opportunity for "Prophylactic" VT Ablation.
Background: Patients with repaired Tetralogy of Fallot (rTOF) are at risk of ventricular tachycardia (VT) and sudden cardiac death (SCD). Most VTs arise from 5 slowly conducting isthmuses (SCAI; conduction velocity ≤ 0.5 m/s) bound by the right ventriculotomy, ventricular septal defect patch, tricuspid and pulmonic valves. Historically, risk stratification electrophysiology studies (EPS) involved programmed ventricular stimulation (PVS) with VT induction guiding ICD implantation and/or VT ablation.
Objective: To evaluate a "prophylactic" strategy of ablating SCAI even in the absence of inducible VT to reduce ICD implantation and arrhythmic events, and to compare this to the "historical" strategy.
Methods: This was a single-center, retrospective cohort study. The "historical cohort" underwent PVS to guide ICD implantation and/or VT ablation. The "prophylactic cohort" underwent right ventricular electroanatomic mapping and ablation of SCAI. A composite endpoint of arrhythmic death, cardiac arrest, sustained VT, and ICD complication was compared between the cohorts.
Results: Ninety-three patients with rTOF had risk stratification EPS. Of 57 prophylactic patients, SCAI were identified/ablated in 33 (58%), 16 (28%) had inducible VT before ablation, and 1 received ICD. Of 35 historical patients, 15 (43%) had inducible VT: 3 had cryoablation during PVR and 11 received ICD. No prophylactic patients met the composite endpoint over median 21 months (IQR 8,35) versus 10 (29%) historical patients over median 125 months (IQR 90,142; p= 0.017). There were no ablation-related complications.
Conclusion: Prophylactic SCAI ablation is associated with fewer ICD implants and a reduction in incident arrhythmic events without ablation-related complications.
期刊介绍:
HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability.
HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community.
The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.